To assess the acute intraocular hypotensive efficacy of brimonidine tartrate 0.2% (a highly selective alpha2-adrenergic agonist) compared with dorzolamide 2% (a topical carbonic anhydrase inhibitor) as adjunct therapy to topical beta-blockers in patients with primary open-angle glaucoma.

Centofanti, M., Manni, G., Gregori, D., Cocco, F., Lorenzano, D., Bucci, M. (2000). Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma. GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 238(4), 302-5.

Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma

MANNI, GIANLUCA;
2000-04-01

Abstract

To assess the acute intraocular hypotensive efficacy of brimonidine tartrate 0.2% (a highly selective alpha2-adrenergic agonist) compared with dorzolamide 2% (a topical carbonic anhydrase inhibitor) as adjunct therapy to topical beta-blockers in patients with primary open-angle glaucoma.
apr-2000
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/30 - MALATTIE APPARATO VISIVO
English
Treatment Outcome; Aged, 80 and over; Male; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Middle Aged; Thiophenes; Female; Intraocular Pressure; Sulfonamides; Drug Therapy, Combination; Quinoxalines; Double-Blind Method; Humans; Tonometry, Ocular; Adrenergic alpha-Agonists; Aged; Cross-Over Studies; Glaucoma, Open-Angle; Ophthalmic Solutions
Centofanti, M., Manni, G., Gregori, D., Cocco, F., Lorenzano, D., Bucci, M. (2000). Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma. GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 238(4), 302-5.
Centofanti, M; Manni, G; Gregori, D; Cocco, F; Lorenzano, D; Bucci, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
comparative brimoni.pdf

accesso aperto

Descrizione: articolo principale
Dimensione 74.24 kB
Formato Adobe PDF
74.24 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/54381
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact